Interleukin-6 (IL-6) mediates its activity through binding to two cell-surface receptors, The high-affinity human IL-6 receptor complex consists of two transmembrane anchored subunits: a ligand-specific, low-affinity IL-6 receptor and the high-affinity converter and signal transducing, gp130, Previously, using recombinant forms of human IL-6 and the extracellular (soluble') domains of the IL-6 receptor (sIL-6R) and gp130 (sgp130), we have shown that the high-affinity IL-6R complex is hexameric, consisting of two molecules each of IL-6, sIL-6R and sgp130 (Ward et al,, 1994, J, Biol, Chem. 269: 23286-23289), This paper investigates the role of the N-terminal region of gp130 in the formation of the high-affinity IL-6R complex.
Using recombinant sgp130 produced with a FLAG(TM) octapeptide epitope (DYKDDDDK) at the N-terminus (sgp130-FLAG), we demonstrate, using biosensor analysis and size-exclusion chromatography, that modification of the N-terminus of sgp130 interferes with the in vitro in solution formation of the stable hexameric IL-6 receptor complex, Rather, sgp130-FLAG interacts with IL-6 and sIL-6R with a much lower affinity and forms a stable lower-order ternary complex. However, this lower-order complex is inconsistent with the solution molecular weight of a trimeric complex, as measured by size-exclusion chromatography. In contrast, N-terminal modification of the sgp130 with the FLAG(TM) epitope did not interfere with the binding of leukemia inhibitory factor or oncostatin-M (other cytokines that signal through gp130) to sgp130,
These data support our model of the hexameric IL-6 receptor complex, which is biased towards the association of two IL-6 . IL-6R . gp130 trimers, and postulates the critical involvement of the N-terminal Ig-like domain of gp130 in tethering the two trimers to form the stable hexamer (Simpson et al,, 1997, Prot. Sei, 6: 929-955).